CLINICAL_TRIALS
trial_result
· 2015-12-07
Clinical Trial Update: Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder [Phase 4]
Summary
Phase 4 trial updates guanfacine for hyperactivity in pervasive developmental disorders; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Pervasive Development Disorders | Phase 4 | Status: COMPLETED | Results posted: 2015-12-07